Dr. Damaj’s research on the use of nicotine and nicotine-like drugs in prevention and treatment of peripheral neuropathy, a common result of chemotherapy, is nationally recognized. With a strong record of NIH grant funding since 2001, he has published 236 peer-reviewed papers and 15 reviews and book chapters. He has shared his work through more than 100 scientific meeting presentations and 35 invited lectures. Dr. Damaj has had a significant impact on VCU, the professional community and the Richmond area through his advocacy work and service on numerous departmental and university committees, community leadership positions and boards.

News of the event can be found here.